Stock Events

Stock Events

Bio Green Med Solution 

$0.8993
96
-$0.01-1.42% 08:27 Today

Statistics

Day High
0.9121
Day Low
0.9121
52W High
8.82
52W Low
0.57
Volume
632
Avg. Volume
-
Mkt Cap
5.04M
P/E Ratio
0.18
Dividend Yield
-
Dividend
-

Upcoming

Dividends

0%Dividend Yield
May 25
$2.25
10Y Growth
N/A
5Y Growth
N/A
3Y Growth
N/A
1Y Growth
N/A

Earnings

18NovExpected
Q2 2025
Q3 2025
Q1 2026
Next
Next
-72
-48.01
-24.03
-0.04
Expected EPS
N/A
Actual EPS
N/A

Financials

-1,886.48%Profit Margin
Unprofitable
2020
2021
2022
2023
2024
2025
747,000Revenue
-14.09MNet Income

People Also Follow

This list is based on the watchlists of people on Stock Events who follow BGMS. It's not an investment recommendation.
Ares Capital
2
ARCC
T. Rowe Price Group
2
TROW
Gladstone Investment
2
GAIN
Gladstone Capital
2
GLAD

Competitors

This list is an analysis based on recent market events. It's not an investment recommendation.
Gilead Sciences
GILD
Mkt Cap171.56B
Gilead Sciences is a biopharmaceutical company that competes in the development of drugs in areas such as oncology, where Cyclacel also operates.
AMGEN
AMGN
Mkt Cap224.63B
Amgen is a biotech firm focusing on human therapeutics, including treatments for cancer, which puts it in direct competition with Cyclacel's oncology focus.
Bristol-Myers Squibb
BMY
Mkt Cap130.39B
Bristol-Myers Squibb is involved in discovering, developing, and delivering innovative medicines, including cancer treatments that compete with Cyclacel's product pipeline.
Pfizer
PFE
Mkt Cap152.69B
Pfizer is a global pharmaceutical corporation with a broad portfolio, including oncology, directly competing with Cyclacel's cancer-focused therapies.
Merck
MRK
Mkt Cap335.14B
Merck is known for its high-quality research and development in pharmaceuticals, including cancer drugs, making it a competitor to Cyclacel.
Novartis
NVS
Mkt Cap286.78B
Novartis is a healthcare company that focuses on innovative medicines, with a strong emphasis on oncology, competing with Cyclacel in the cancer treatment market.
Abbvie
ABBV
Mkt Cap440.83B
AbbVie operates in the discovery of new medicines, including for cancer, directly competing with Cyclacel's research and development in oncology.
Astrazeneca
AZN
Mkt Cap242.64B
AstraZeneca is a global, science-led biopharmaceutical business that focuses on the discovery, development, and commercialization of prescription medicines, including in oncology, competing with Cyclacel.
Roche
RHHBY
Mkt Cap334.28B
Roche Holding AG is a pioneer in healthcare, with a strong focus on pharmaceuticals and diagnostics in oncology, making it a competitor to Cyclacel.
Johnson & Johnson
JNJ
Mkt Cap627.42B
Johnson & Johnson is a diverse healthcare company that has a pharmaceutical segment involved in the development of oncology treatments, competing with Cyclacel.

About

Bio Green Med Solution Inc is engaged in the supply and trading of protective and fire safety equipment. The company distributes products such as fire extinguishers, foam systems, fire-resistant doors, personal protective equipment, and safety apparel. It also provides fire safety systems, including sprinkler systems, fire alarm systems, valves, and CO2 systems. The company operates across commercial, industrial, healthcare, and residential sectors, with a focus on distribution and compliance with applicable safety standards.
Show more...
CEO
Sing Ee Wong
Employees
19
Country
Malaysia
ISIN
US23254L8761
WKN
000A3E2F3

Listings

MU
DE
UXI4.MU
XNAS
US
BGMS
BOATS
BOATS
BGMS.BOATS
MU
DE
UXI1.MU

0 Comments

Share your thoughts

FAQ

What is Bio Green Med Solution stock price today?▼
The current price of BGMS is $0.90 USD — it has decreased by -1.42% in the past 24 hours. Watch Bio Green Med Solution stock price performance more closely on the chart.
What is Bio Green Med Solution stock ticker?▼
Depending on the exchange, the stock ticker may vary. For instance, on XNAS exchange Bio Green Med Solution stocks are traded under the ticker BGMS.
What is Bio Green Med Solution market cap?▼
Today Bio Green Med Solution has the market capitalization of 5.04M
When is the next Bio Green Med Solution earnings date?▼
Bio Green Med Solution is going to release the next earnings report on November 18, 2026.
What is Bio Green Med Solution revenue for the last year?▼
Bio Green Med Solution revenue for the last year amounts to 747,000 USD.
What is Bio Green Med Solution net income for the last year?▼
BGMS net income for the last year is -14.09M USD.
Does Bio Green Med Solution pay dividends?▼
Yes, BGMS dividends are paid annual. The last dividend per share was 2.25 USD. As of today, Dividend Yield (FWD)% is 0%.
How many employees does Bio Green Med Solution have?▼
As of August 19, 2026, the company has 19 employees.
In which sector is Bio Green Med Solution located?▼
Bio Green Med Solution operates in the Health & Wellness sector.
When did Bio Green Med Solution complete a stock split?▼
The last stock split for Bio Green Med Solution was on July 07, 2025 with a ratio of 1:15.
Where is Bio Green Med Solution headquartered?▼
Bio Green Med Solution is headquartered in BERKELEY HEIGHTS, Malaysia.